Form 4 for BLCO Bausch & Lomb Corp
Accepted 2026-02-20 00:00:00 ET · period of report 2026-02-18 · accession 0001860742-26-000013 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-02-20 | 2026-02-18 | BLCO | Bonnefoy Luc | Pres, Surgical | A - Grant | $0.00 | +10.2K | 87.6K | +13% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares, No Par Value | 2026-02-18 | A | A | 10,202 | $0.00 | 87,564 | D | — | — | (F1) Represents common shares, no par value, of Bausch + Lomb Corporation underlying an award of performance stock units ("PSUs") originally granted to the reporting person on March 1, 2023 under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan, as amended and restated, that satisfied the applicable performance conditions as of February 18, 2026. The earned PSUs will vest on March 1, 2026, subject generally to the reporting person's continued employment through such date. |